Basics RAPT Therapeutics, Inc. IPO Date: October 28, 2019 Sector: Healthcare Industry: Biotech Market Cap: $129.09M Activated in VL: True Average Daily Range Avg Daily Range: $0.72 | 3.98% Avg Daily Range (30 D): $0.06 | 6.48% Avg Daily Range (90 D): $0.05 | 4.88% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): .83M Avg Daily Volume (90 D): .69M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 249 Avg Trade Size (Sh.) (90 D): 207 Institutional Trades Total Inst.Trades: 1,055 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.7M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $1.02M Avg Closing Trade (90 D): $1.56M Avg Closing Volume: 82.85K         News Jan 6, 2025 @ 1:00 PM RAPT Therapeutics Names Lori Lyons-Williams Cha... Source: Rapt Therapeutics, Inc. Jul 19, 2024 @ 2:00 PM Agenus (AGEN) Tanks on Colorectal Cancer Study Int... Source: N/A Jul 17, 2024 @ 2:01 PM Arcutis (ARQT) Stock Rises 31% in the Past Month: ... Source: Zacks Equity Research Jul 16, 2024 @ 2:30 PM Lisata (LSTA) Stock Rallies More Than 30% YTD: Her... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.48 $-.08 $-1.22 Diluted EPS $-2.48 $-.08 $-1.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -116.51M $ -17.17M $ -53.25M Operating Income / Loss $ -122.85M $ -19.27M $ -54.47M Cost of Revenue $ $ $ Net Cash Flow $ 124.42M $ M $ 131.84M PE Ratio